Polymyositis, invasion of non-necrotic muscle fibres, and the art of repetition

British Medical Journal

Volumn 329, Issue 7480, 2004, Pages 1464-1467

  Hengstman, Gerald J D ^a   Van Engelen, Baziel G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; CELL INVASION; HISTOPATHOLOGY; HISTORY; HUMAN; INCLUSION BODY MYOSITIS; INFLAMMATION; INFORMATION RETRIEVAL; LYMPHOCYTIC INFILTRATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MUSCLE CELL; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW;

EID: 10844296447     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.329.7480.1464     Document Type: Review

References (17)

1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.
2. Barohn RJ, Amato AA, Sahenk Z, Kissel JT, Mendell JR. Inclusion body myositis: explanation for poor response to immunosuppressive therapy. Neurology 1995;45:1302-4.
3. Amato AA, Gronseth GS Jackson CE, Wolfe GI, Katz JS, Bryan WW, et al. Inclusion body myositis: clinical and pathological boundaries. Ann Neurol 1996;40:581-6.
4. Miller FW, Rider LG, Plotz PH, Isenberg DA, Oddis CV. Diagnostic criteria for polymyositis and dermatomyositis. Lancet 2003;362:1762-3.
5. Van der Meulen MFG, Bronner IM, Hoogendijk JE, Burger H, Van Venrooij WJ, Voskuyl AE, et al. Polymyositis: an overdiagnosed entity. Neurology 2003;61:316-21.
6. Amato AA, Griggs RC. Unicorns, dragons, polymyositis, and other mythological beasts. Neurology 2003;61:288-90.
7. Miller FW, Rider LG, Plotz PH, Rutkovc SB, Pestronk A, Wortmann RL, et al. Polymyositis: an overdiagnosed entity. Neurology 2004;63:402.
8. Bradley WG. Polymyositis: an overdiagnosed entity. Neurology 2004;63:402.
9. Hengstman GJD, Van Engelen BGM. Polymyositis: an overdiagnosed entity. Neurology 2004;63:402-3.
10. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
11. Carpenter S, Karpati G. The major inflammatory myopathies of unknown cause. Pathol Annu 1981;16:205-37.
12. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. 1: Quantitation of subsets according to diagnosis and sited of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208.
13. Ringel SP, Carry MR, Aguilera AJ, Starcevich JM. Quantitative histopathology of the inflammatory myopathies. Arch Neurol 1986;43:1004-9.
14. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989;20:224-31.
15. Van der Meulen MFG, Hoogendijk JE, Jansen GH, Veldman H, Wokke JH. Absence of characteristic features in two patients with inclusion body myositis. J Neurol Neurosurg Psychiatry 1998;64:396-8.
16. Whitaker JN. Inflammatory myopathy: a review of etiologic and pathogenetic factors. Muscle Nerve 1982;5:573-92.
17. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004;14:337-45.